153 related articles for article (PubMed ID: 7643878)
1. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice.
Asselin I; Tremblay M; Vilquin JT; Guérette B; Roy R; Tremblay JP
Muscle Nerve; 1995 Sep; 18(9):980-6. PubMed ID: 7643878
[TBL] [Abstract][Full Text] [Related]
2. Increased granzyme B mRNA after alloincompatible myoblast transplantation.
Guérette B; Roy R; Tremblay M; Asselin I; Kinoshita I; Puymirat J; Tremblay JP
Transplantation; 1995 Nov; 60(9):1011-6. PubMed ID: 7491674
[TBL] [Abstract][Full Text] [Related]
3. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice.
Asselin I; Tremblay M; Vilquin JT; Guérette B; Tremblay JP
Transplant Proc; 1994 Dec; 26(6):3389. PubMed ID: 7527970
[No Abstract] [Full Text] [Related]
5. PCR analysis of dystrophin gene mutation and expression.
Chamberlain JS; Farwell NJ; Chamberlain JR; Cox GA; Caskey CT
J Cell Biochem; 1991 Jul; 46(3):255-9. PubMed ID: 1774226
[TBL] [Abstract][Full Text] [Related]
6. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
7. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
Moisset PA; Gagnon Y; Karpati G; Tremblay JP
Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
[TBL] [Abstract][Full Text] [Related]
8. [Dystrophin expression and pathology of diaphragm muscles of mdx mice after xenogenic bone marrow stem cell transplantation].
Zhang YN; Zhang C; Yu MJ; Wang SH; Li MS; Huang H; Xiong F; Feng SW; Liu TY; Lu XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):53-8. PubMed ID: 16495176
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
11. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
[TBL] [Abstract][Full Text] [Related]
13. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection.
Huard J; Roy R; Guérette B; Verreault S; Tremblay G; Tremblay JP
Muscle Nerve; 1994 Feb; 17(2):224-34. PubMed ID: 8114793
[TBL] [Abstract][Full Text] [Related]
14. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice.
Kinoshita I; Vilquin JT; Tremblay JP
Muscle Nerve; 1995 Aug; 18(8):834-41. PubMed ID: 7630343
[TBL] [Abstract][Full Text] [Related]
16. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
Kinoshita I; Huard J; Tremblay JP
Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
[TBL] [Abstract][Full Text] [Related]
17. [Transplantation of 3H-thymidine-labeled human bone marrow-derived mesenchymal stem cells in mdx mice].
Liu TY; Li JL; Yao XL; Dong QW; Su QX; Feng SW; Li CM; Zeng Y; Liu ZG; Zhang C; Liu CZ
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):498-502. PubMed ID: 15897118
[TBL] [Abstract][Full Text] [Related]
18. [Muscle regeneration in mdx mouse, and a trial of normal myoblast transfer into regenerating dystrophic muscle].
Takemitsu M; Arahata K; Nonaka I
Rinsho Shinkeigaku; 1990 Oct; 30(10):1066-72. PubMed ID: 2279357
[TBL] [Abstract][Full Text] [Related]
19. [Dystrophin expression in mdx mice after bone marrow stem cells transplantation].
Feng SW; Zhang C; Yao XL; Yu MJ; Li JL; Chen SL; Liu TY; Lu XL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):178-81. PubMed ID: 16733899
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
